STMH (Stem Holdings) Revenue: $0.00 Mil (TTM As of Sep. 2023)


STMH Stem Holdings Inc STMH
12 GF Score
Price $0.00
View Full Analysis

What is Stem Holdings Revenue?

Stem Holdings STMH -99.00% 12 Revenue is $0.00 Mil as of Sep. 2023. GuruFocus rates STMH with a GF Score™ of 12/100.

Stem Holdings's revenue for the three months ended in Sep. 2023 was $-11.78 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil. Stem Holdings's Revenue per Share for the three months ended in Sep. 2023 was $-4.21. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.63.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Stem Holdings  (OTCPK:STMH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Stem Holdings Revenue Related Terms


Stem Holdings Revenue Historical Data

* Premium members only.

The historical data trend for Stem Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Holdings Revenue Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Revenue
Get a 7-Day Free Trial 2.45 13.97 20.94 0.00 0.00

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.52 4.06 3.89 3.83 -11.78

STMH vs NXEN, VFRM, ENDPQ: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Revenue falls into.


STMH
12GF Score
Stem Holdings Inc STMH
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stem Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.00 Mil mean?
Stem Holdings (STMH) has a Revenue of $0.00 Mil as of Sep. 2023. Revenue is the total amount a company generates as sales through its operations. View historical data on Stem Holdings and its competitors.
Is Stem Holdings' Revenue too high?
Stem Holdings' current Revenue is $0.00 Mil. Overall, Stem Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Stem Holdings' Revenue compare to NXEN and VFRM?
Stem Holdings' Revenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Stem Holdings and its competitors. Stem Holdings's current Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Holdings stock overvalued right now?
Stem Holdings (STMH) has a current Revenue of $0.00 Mil. The current Revenue is $0.00 Mil. Stem Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Stem Holdings (STMH), the current Revenue is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stem Holdings Business Description

Address 2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
12GF Score

Get the complete analysis for STMH

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price